RECRUITING

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial compares telephone-based physical activity coaching to self monitored physical activity for improving physical function in older adults who are undergoing surgery for lung cancer and their caregivers. Lung cancer surgery in older adults is associated with functional declines and unique challenges. Performing physical activity around the time of surgery has been shown to improve functional outcomes in patients and exercise programs delivered via telehealth may improve access and convenience for patients and minimize participant burden. Telephone-based physical activity coaching may improve physical functioning for older adults with lung cancer who are undergoing surgery.

Official Title

SR2204: a Randomized Phase III Trial of a Perioperative Physical Activity Intervention in Older Adults with Lung Cancer and Their Family Caregivers

Quick Facts

Study Start:2023-12-05
Study Completion:2028-05-16
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06196008

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * PATIENT: Documented informed consent of the participant and/or legally authorized representative
  2. * PATIENT: Agreement to allow the use of preoperative chest CT scan for exploratory analysis, if available
  3. * PATIENT: Agreement to wear pedometer during study duration
  4. * If unwilling, exceptions may be granted with study primary investigator (PI) approval
  5. * PATIENT: Age \>= 65 years
  6. * PATIENT: Ability to read and understand English or Spanish and willingness to complete participant-reported outcomes and assessments
  7. * PATIENT: Diagnosis of lung cancer or presumed lung cancer (as determined by surgeons) in patient
  8. * PATIENT: Scheduled to undergo lung surgery for lung cancer or suspected lung cancer with curative intent (neoadjuvant therapy allowed)
  9. * PATIENT: Adults lacking capacity to consent in the opinion of the attending surgeon will not be enrolled
  10. * FCG: Documented informed consent of the participant and/or legally authorized representative
  11. * FCG: Age \>= 18
  12. * FCG: Ability to read and understand English or Spanish and willingness to complete participant-reported outcomes and assessments
  13. * FCG: Adults lacking capacity to consent in the opinion of the attending surgeon will not be enrolled
  1. * PATIENT: Lung surgery is scheduled in less than 14 calendar days from the time of registration
  2. * PATIENT: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including exercise program and compliance issues related to feasibility/logistics)
  3. * FCG: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including exercise program and compliance issues related to feasibility/logistics)

Contacts and Locations

Study Contact

Dan Raz, MD
CONTACT
626-471-7100
draz@coh.org

Principal Investigator

Dan Raz, MD
PRINCIPAL_INVESTIGATOR
City of Hope Medical Center

Study Locations (Sites)

University of California
Davis, California, 95616
United States
City of Hope Medical Center
Duarte, California, 91010
United States
Standard University
Standford, California, 94305
United States
Standford University
Stanford, California, 94305
United States
Yale New Haven Medical Center
New Haven, Connecticut, 06510
United States
Moffitt Cancer Center
Tampa, Florida, 33612
United States
Northwestern University
Evanston, Illinois, 60208
United States
Massachusetts General Hospital (MGH) / Harvard
Boston, Massachusetts, 02114
United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216
United States
Duke University
Durham, North Carolina, 27710
United States
Ohio State University
Columbus, Ohio, 43210
United States
University of Tennessee Health Science Center
Memphis, Tennessee, 38120
United States
MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: City of Hope Medical Center

  • Dan Raz, MD, PRINCIPAL_INVESTIGATOR, City of Hope Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-05
Study Completion Date2028-05-16

Study Record Updates

Study Start Date2023-12-05
Study Completion Date2028-05-16

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Carcinoma